Fresenius Medical Care AG (FMCQF)
OTCMKTS · Delayed Price · Currency is USD
56.00
+0.36 (0.64%)
At close: Oct 21, 2025
Fresenius Medical Care AG Revenue
Fresenius Medical Care AG had revenue of 4.79B EUR in the quarter ending June 30, 2025, with 0.53% growth. This brings the company's revenue in the last twelve months to 19.52B, up 0.53% year-over-year. In the year 2024, Fresenius Medical Care AG had annual revenue of 19.34B, down -0.61%.
Revenue (ttm)
19.52B EUR
Revenue Growth
+0.53%
P/S Ratio
0.69
Revenue / Employee
175.03K EUR
Employees
111,513
Market Cap
15.88B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19.34B | -117.71M | -0.61% |
Dec 31, 2023 | 19.45B | 55.60M | 0.29% |
Dec 31, 2022 | 19.40B | 1.78B | 10.10% |
Dec 31, 2021 | 17.62B | -240.38M | -1.35% |
Dec 31, 2020 | 17.86B | 382.51M | 2.19% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Oncology Network | 1.76B |
Veradigm | 588.02M |
Jushi Holdings | 256.36M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Silence Therapeutics | 27.17M |
Nuo Therapeutics | 1.95M |
Northwest Biotherapeutics | 1.09M |
Fresenius Medical Care AG News
- 21 days ago - Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement - PRNewsWire
- 27 days ago - FMS Crosses Below Key Moving Average Level - Nasdaq
- 4 weeks ago - Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now - Nasdaq
- 4 weeks ago - Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment - PRNewsWire
- 2 months ago - Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework - PRNewsWire
- 2 months ago - Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Fresenius Medical Care sees limited impact from tariffs, says CEO - CNBC
- 2 months ago - Fresenius Medical Care reports Q2 results - Seeking Alpha